170 related articles for article (PubMed ID: 6310019)
1. Epstein-Barr virus transformation of human pre-B cells.
Hansson M; Falk K; Ernberg I
J Exp Med; 1983 Aug; 158(2):616-22. PubMed ID: 6310019
[TBL] [Abstract][Full Text] [Related]
2. Progenitor and pre-B lymphocytes transformed by Epstein-Barr virus.
Ernberg I; Falk K; Hansson M
Int J Cancer; 1987 Feb; 39(2):190-7. PubMed ID: 3026970
[TBL] [Abstract][Full Text] [Related]
3. Immature B cells in fetal development and immunodeficiency: studies of IgM, IgG, IgA and IgD production in vitro using Epstein-Barr virus activation.
Pereira S; Webster D; Platts-Mills T
Eur J Immunol; 1982 Jul; 12(7):540-6. PubMed ID: 6288397
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes.
Gregory CD; Kirchgens C; Edwards CF; Young LS; Rowe M; Forster A; Rabbitts TH; Rickinson AB
Eur J Immunol; 1987 Aug; 17(8):1199-207. PubMed ID: 3040424
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
Koizumi S
Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
[TBL] [Abstract][Full Text] [Related]
6. In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of anti-melanoma antibodies by some transformed cells.
Watson DB; Burns GF; Mackay IR
J Immunol; 1983 May; 130(5):2442-7. PubMed ID: 6300247
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of EBV-transformable human B lymphocyte populations.
Chan MA; Stein LD; Dosch HM; Sigal NH
J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
[TBL] [Abstract][Full Text] [Related]
8. Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells.
Hibi T; Chan MA; Petsche D; Dosch HM
J Immunol; 1986 May; 136(9):3211-8. PubMed ID: 3007613
[TBL] [Abstract][Full Text] [Related]
9. Cord blood mononuclear cell transformation assay for screening for the presence of Epstein-Barr virus.
Lucas KG; Burton R; Heilman DK; Pollok K; Emanuel D
J Hematother; 1997 Dec; 6(6):587-90. PubMed ID: 9483194
[TBL] [Abstract][Full Text] [Related]
10. Properties and heterogeneity of human fetal pre-B cells transformed by EBV.
Hui MF; Lam P; Dosch HM
J Immunol; 1989 Oct; 143(8):2470-9. PubMed ID: 2551960
[TBL] [Abstract][Full Text] [Related]
11. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
Stuart AD; Stewart JP; Arrand JR; Mackett M
Oncogene; 1995 Nov; 11(9):1711-9. PubMed ID: 7478598
[TBL] [Abstract][Full Text] [Related]
12. Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
MacArthur GJ; Wilson AD; Birchall MA; Morgan AJ
J Virol; 2007 May; 81(9):4766-75. PubMed ID: 17314172
[TBL] [Abstract][Full Text] [Related]
13. Antibodies binding granulocyte-macrophage colony stimulating factor produced by cord blood-derived B cell lines immortalized by Epstein-Barr virus in vitro.
Revoltella RP; Laricchia Robbio L; Liberati AM; Reato G; Foa R; Funaro A; Vinante F; Pizzolo G
Cell Immunol; 2000 Sep; 204(2):114-27. PubMed ID: 11069719
[TBL] [Abstract][Full Text] [Related]
14. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
Tosato G; Blaese RM; Yarchoan R
J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
[TBL] [Abstract][Full Text] [Related]
15. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
16. Expression of the CD2 molecule on human B lymphoid progenitors.
Muraguchi A; Kawamura N; Hori A; Horii Y; Ichigi Y; Kimoto M; Kishimoto T
Int Immunol; 1992 Aug; 4(8):841-9. PubMed ID: 1384685
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CD7+CD19+ lymphoid cells after Epstein-Barr virus transformation.
Panzer-Grümayer ER; Panzer S; Wolf M; Majdic O; Haas OA; Kersey JH
J Immunol; 1993 Jul; 151(1):92-9. PubMed ID: 7686950
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody to the Epstein-Barr virus receptor induces human B lymphocyte activation and differentiation.
Nemerow GR; McNaughton ME; Cooper NR
Trans Assoc Am Physicians; 1985; 98():290-300. PubMed ID: 3022444
[No Abstract] [Full Text] [Related]
19. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
Wilson AD; Morgan AJ
J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
[TBL] [Abstract][Full Text] [Related]
20. Prenatal and neonatal synthesis of IgE.
Delespesse G; Sarfati M; Lang G; Sehon AH
Monogr Allergy; 1983; 18():83-95. PubMed ID: 6358870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
